SyntekaBio

226330 · KOSDAQ · Information Technology · SMALL CAP

A new supply contract.

SyntekaBio disclosed a supply contract with Geovista Co., Ltd., worth US$393K, about 15.46% of its recent annual revenue, running through Sep 2026.

Supply contract(Supply contract signed)· FILED 2026-09-11· RCEPT 20260911900264

US$393KContract value
15.46%vs. recent revenue
Sep 2026Throughfrom Sep 2026

Converted at 1 USD ≈ ₩1,348.17 (filing-date rate, 2026-09-10 close)

What happened

SyntekaBio disclosed a supply contract with Geovista Co., Ltd., worth US$393K, about 15.46% of its recent annual revenue, running through Sep 2026.

For context, this single contract equals about 15.46% of the company's most recent annual revenue.

CounterpartyGeovista Co., Ltd.
Contract valueUS$393K
vs. recent revenue15.46%
ThroughSep 2026 (from Sep 2026)
Filed2026-09-11, Supply contract signed
SourceDART rcept 20260911900264 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-11 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.